Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis-Reference-Cited by-同舟云学术

Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis

Published:2021-01-05 Issue:2 Volume:51 Page:201-215
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Chuma Makoto¹^ORCID,Uojima Haruki²,Hiraoka Atsushi³,Kobayashi Satoshi⁴,Toyoda Hidenori⁵^ORCID,Tada Toshifumi⁶^ORCID,Hidaka Hisashi²^ORCID,Iwabuchi Shogo⁷,Numata Kazushi¹,Itobayashi Ei⁸,Itokawa Norio⁹,Kariyama Kazuya¹⁰,Ohama Hideko¹¹,Hattori Nobuhiro¹²,Hirose Shunji¹³,Shibata Hiroshi¹⁴,Tani Joji¹⁵,Imai Michitaka¹⁶,Tajiri Kazuto¹⁷^ORCID,Moriya Satoshi¹,Wada Naohisa²,Iwasaki Shuitirou²,Fukushima Taito⁴,Ueno Makoto⁴,Yasuda Satoshi⁵,Atsukawa Masanori⁹^ORCID,Nouso Kazuhiro¹⁰^ORCID,Fukunishi Shinya¹¹,Watanabe Tsunamasa¹²,Ishikawa Toru¹⁶,Nakamura Shinichiro⁶,Morimoto Manabu⁴,Kagawa Tatehiro¹³,Sakamoto Michiie¹⁸,Kumada Takashi⁵¹⁹^ORCID,Maeda Shin²⁰

Affiliation:

1. Gastroenterological Center Yokohama City University Medical Center Yokohama Japan

2. Department of Gastroenterology, Internal Medicine Kitasato University School of Medicine Sagamihara Japan

3. Gastroenterology Center Ehime Prefectural Central Hospital Matsuyama Japan

4. Hepatobiliary and Pancreatic Medical Oncology Kanagawa Cancer Center Hospital Yokohama Japan

5. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Japan

6. Department of Gastroenterology Himeji Red Cross Hospital Himeji Hyogo Japan

7. Department of Gastroenterology Shonan Fujisawa General Hospital Fujisawa Japan

8. Department of Gastroenterology Asahi General Hospital Asahi Japan

9. Division of Gastroenterology and Hepatology Nippon Medical School Tokyo Japan

10. Department of Gastroenterology Okayama City Hospital Okayama Japan

11. Second Department of Internal Medicine Osaka Medical College Takatsuki Japan

12. Division of Gastroenterology and Hepatology, Department of Internal Medicine St. Marianna University School of Medicine Kawasaki Japan

13. Division of Gastroenterology and Hepatology, Department of Internal Medicine Tokai University School of Medicine Isehara Japan

14. Department of Gastroenterology Tokushima Prefectural Central Hospital Tokushima Japan

15. Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Miki Kagawa Japan

16. Department of Gastroenterology Saiseikai Niigata Hospital Niigata Japan

17. Department of Gastroenterology Toyama University Hospital Toyama Japan

18. Department of Pathology Keio University School of Medicine Tokyo Japan

19. Faculty of Nursing Gifu Kyoritsu University Ogaki Japan

20. Department of Gastroenterology Yokohama City University Hospital Yokohama Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13592

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Epidemiology and Management of Hepatocellular Carcinoma

3. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

4. The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis

5. Phase I/II Study of Radiologic Hepatic Arterial Infusion of Fluorouracil Plus Systemic Irinotecan for Unresectable Hepatic Metastases from Colorectal Cancer: Japan Clinical Oncology Group Trial 0208-DI

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment;Clinical and Molecular Hepatology;2023-10-01

2. Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study;Journal of Hepatocellular Carcinoma;2023-09

3. Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan;Drugs - Real World Outcomes;2023-01-05

4. Comparison of the effects of lenvatinib and sorafenib on survival in patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2023-01

5. An overview: Management of patients with advanced hepatocellular carcinoma;BioScience Trends;2022-12-25